期刊文献+

血清同型半胱氨酸及载脂蛋白A-Ⅰ水平与冠心病的关联分析 被引量:17

Correlation analysis of the level of serum homocysteine and apolipoprotein A-Ⅰ with risk of coronary heart disease
下载PDF
导出
摘要 目的探讨血清同型半胱氨酸(homocysteine,Hcy)以及载脂蛋白(apolipoprotein,Apo) A-Ⅰ水平与冠心病以及冠状动脉病变程度之间的关系。方法选择2016年11月至2018年2月宣城市人民医院经冠状动脉造影诊断为冠心病的病人168例,对照选择同期在该院检查排除冠心病的人群179例。血清Hcy采用循环酶法测定,血清Apo A-Ⅰ采用美国BECKMAN DX-800型生化分析仪测定。两变量间的相关性以Spearman秩相关系数(rs)表示。采用二分类logistic回归分析血清Hcy及Apo A-Ⅰ与冠心病风险之间的独立关联。结果冠心病组病人血清Hcy水平[M(P25,P75)]为14.18(10.99,15.43)μmol/L,显著高于对照组9.03(8.26,9.70)μmol/L,Z=-11.69,P<0.001。冠心病组病人血清Apo A-Ⅰ水平[M(P25,P75)]为1.15(0.88,1.42)g/L,显著低于对照组1.64(1.35,1.82) g/L,Z=-9.81,P<0.001。二分类logistic回归分析结果显示:血清Hcy水平每增加1个三分位等级,冠心病发病风险的OR值为2.39(95%CI:1.53~3.70);血清Apo A-Ⅰ水平每增加1个三分位等级,冠心病发病风险的OR值为0.79(95%CI:0.65~0.96)。相关分析结果显示:血清Hcy均与血管病变支数及SYNTAX评分呈正相关关系(rs=0.252,P<0.05),Apo A-Ⅰ与血管病变支数呈负相关(rs=-0.257,P<0.05)。结论血清Hcy水平与冠心病风险及冠脉病变程度呈负相关,Apo A-Ⅰ水平与冠心病风险及冠脉病变程度呈正相关。 Objective To investigate the association of the level of serum homocysteine(Hcy) and apolipoprotein A-Ⅰ(Apo A-Ⅰ) with risks of coronary heart disease(CHD) and the severity of coronary artery lesions.Methods A total of 168 cases of CHD diagnosed by coronary arteriography in The People’s Hospital of Xuancheng City from November 2016 to February 2018 were recruited in this study.And 179 cases of controls were selected from these who were free of coronary heart disease in the hospital during the same period.Serum Hcy was determined by cyclic enzymatic method,and the serum Apo A-Ⅰ was determined by BECKMAN DX-800 biochemical analyzer.The correlation between the two variables was expressed by Spearman rank correlation coefficient(rs).Results There was no significant difference in characteristics of age and gender between CHD and control group.The level of serum Hcy in the CHD group was14.18(10.99,15.43)μmol/L,which was significantly higher than that in the control group 9.03(8.26,9.70)μmol/L(Z=-11.69,P<0.001).The serum Apo A-Ⅰ level 1.15(0.88,1.42) g/L in patients with CHD was significantly lower than that in the control group 1.64(1.35,1.82) g/L,(Z=-9.81,P<0.001).The binary logistic regression analysis indicated that the OR of the risk of CHD was 2.39(95% CI:1.53-3.70) for per tertile increase in serum Hcy,and the OR of the risk of CHD was 0.79(95% CI:0.65-0.96) for per tertile increase in serum Apo A-Ⅰ.The correlation analysis results showed that serum Hcy was positively correlated with the number of vascular lesions and the scores of SYNTAX(rs=0.252,P<0.05),and Apo A-Ⅰ was negatively correlated with the number of vascular lesions(rs=-0.257,P<0.05).Conclusion The level of serum Hcy is negatively correlated with the risk of coronary heart disease and the degree of coronary artery disease.The level of Apo A-Ⅰ is positively associated with coronary heart disease and the degree of vascular lesions.
作者 李镇 邵名亮 胡龙 冯启凡 LI Zhen;SHAO Mingliang;HU Long;FENG Qifan(Department of Cardiology,The People's Hospital of Xuancheng City,Xuancheng,Anhui 242000,China)
出处 《安徽医药》 CAS 2019年第8期1543-1546,共4页 Anhui Medical and Pharmaceutical Journal
关键词 冠心病 半胱氨酸 载脂蛋白A-Ⅰ 冠状血管 Coronary disease Cysteine Apolipoprotein A-Ⅰ Coronary vessels
  • 相关文献

参考文献10

二级参考文献55

  • 1徐勇霞,傅明德,徐燕华,杨鲁川.冠心病患者冠脉狭窄程度与血清HDL亚类组成的关系[J].四川大学学报(医学版),2004,35(4):500-502. 被引量:5
  • 2董艳玲,王风.急性冠脉综合征的危险因素[J].中国误诊学杂志,2006,6(21):4120-4121. 被引量:16
  • 3Pranavchand R,Reddy BM.Current status of understanding of the genetic etiology of coronary heart disease[J].J Postgrad Med,2013,59(1):30-41. 被引量:1
  • 4O'Donnell MJ,Xavier D,Liu L,et al.Risk factors for ischaemic and intracerebral haemorrhagic stroke in 22 countries(the INTERSTROKE study):a case-control study[J].Lancet,2010,376 (9735):112-123. 被引量:1
  • 5Yang D,Liu XB,Xiang NX,et al.The Correlation between Lipids Ratio and Degree of Coronary Artery Stenosis[J].High Blood Press Cardiovasc Prey,2011,18 (2):53-56. 被引量:1
  • 6Perk J,De Backer G,Gohlke H,et al.European Guidelines on cardiovascular disease prevention in clinical practice (version 2012).The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)[J].Eur Heart J,2012,33 (13):1635-1701. 被引量:1
  • 7Margolis KL,Davis BR,Baimbridge C,et al.Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care:the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)[J].J Clin Hypertens (Greenwich),2013,15 (8):542-554. 被引量:1
  • 8Adedeji OO,Oyakhire GK,Saeed AK,et al.Effectiveness of intervemions to reduce coronary heart disease risk[J].West Afr J Med,2011,30(3):197-201. 被引量:1
  • 9Carnevale SGP,Pedrazzoli R,Onolfo S,et al.ApoB/apoA-Ⅰ ratio is better than LDL-C in detecting cardiovascular risk[J].Nutr Metab Cardiovasc Dis,2011,21 (6):406-411. 被引量:1
  • 10Leiviska J,Sundvall J,Alfthan G,et al.Apolipoprotein A-Ⅰ,apolipoprotein B,and apolipoprotein B/apolipoprotein A-Ⅰ ratio:reference intervals compared with values in different pathophysiological conditions from the FINRISK 2007 study[J].Clin Chim Acta,2011,412(11/12):1146-1150. 被引量:1

共引文献1057

同被引文献214

引证文献17

二级引证文献121

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部